SpringWorks Therapeutics is a commercial-stage biopharmaceutical company dedicated to applying a precision medicine approach to develop and deliver transformative therapies for individuals suffering from severe rare diseases and cancer. With a diversified oncology pipeline that includes clinical trials for both rare tumor types and prevalent genetically defined cancers, SpringWorks is committed to operational excellence in clinical development. The company has successfully advanced its lead product candidates into late-stage trials and has established multiple collaborations with industry and academic innovators to maximize the potential of its portfolio and provide more solutions for cancer patients.